Key facts
- This page summarizes Terah Renee Krigsvold's Form 3 filing for INVO Fertility, Inc. (IVF).
- 0 reported transactions and 7 derivative rows are listed below.
- Accepted by SEC: 13 Jan 2026, 20:03.
Terah Renee Krigsvold - 30 Dec 2025 Form 3 Insider Report for INVO Fertility, Inc. (IVF)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- IVF
- Reported as of
- 30 Dec 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Terah Krigsvold
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Terah Renee Krigsvold filed Form 3 for INVO Fertility, Inc. (IVF) on 13 Jan 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002103834
Primary reporting owner
Krigsvold Terah Renee
- Relationship
- Chief Financial Officer
- Address
- C/O INVO FERTILITY, INC., 5582 BROADCAST COURT, SARASOTA
- Signature
- /s/ Terah Krigsvold
- Signature date
- 13 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IVF
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1
- Date
- 30 Dec 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3
- Exercise price
- $17683.20
- Footnotes
- F1
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3
- Exercise price
- $17280.00
- Footnotes
- F2
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2
- Exercise price
- $2304.00
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2
- Exercise price
- $2983.68
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2
- Exercise price
- $3882.24
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11
- Exercise price
- $2119.68
- Footnotes
- F3
IVF
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 30 Dec 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,375
- Exercise price
- $8.96
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
The option vested in monthly increments over a period of 36 months from January 1, 2021.
Footnote F2
The option vested in monthly increments over a period of 36 months from February 11, 2022.
Footnote F3
The option vests in 12 equal installments beginning on May 18, 2023 and on the last day of each calendar quarter thereafter until fully vested.
Footnote F4
The option vests in four equal installments beginning on the first day of the calendar quarter following August 26, 2025 and on the first day of each calendar quarter thereafter until fully vested.